Prosecution Insights
Last updated: October 27, 2026

Svetlana M Ivanova, USPTO Patent Examiner

Listed by the USPTO as IVANOVA, SVETLANA M

Tech Center 1600 • Art Units: 1600 1626 1627

This examiner grants 51% of resolved cases

Analysis

Svetlana M. Ivanova has 851 resolved cases in Art Unit 1600 of Tech Center 1600. The allowance rate is 50.9 percent. A high interview lift of 51.8 percent indicates that interviews are exceptionally effective for this examiner, correlating with a much higher probability of allowance compared to the 50.9 percent baseline. This suggests that direct communication is a primary driver of success in this docket.

The median days to allowance is 978. BASF SE, Regenall Limited, and Nestlé S.A. are the top companies. Scully Scott Murphy & Presser, PC, Workman Nydegger, and ArentFox Schiff LLP are the leading firms. The 851 resolved cases provide a robust data set for these metrics. Practitioners can use the 50.9 percent allowance rate and 978 days to allowance to set expectations for the prosecution timeline. The 51.8 percent interview lift offers a clear incentive for direct engagement.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.9%
Allow Rate
-9.1% vs TC avg
886
Total Applications
+51.8%
Interview Lift
978
Avg Prosecution Days
Based on 851 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
14.1%
§102 Novelty
45.2%
§103 Obviousness
22.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18793148 Herbicidal compositions comprising saflufenacil Non-Final OA BASF SE
18014163 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VI Non-Final OA BASF SE
17736496 COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE Final Rejection SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
18726477 EXTERNAL-USE SKIN PREPARATION COMPOSITION Non-Final OA SHISEIDO COMPANY, LTD.
17845399 Pharmaceutical Composition for Treatment or Prevention of Multiple Inflammatory disorders Non-Final OA AARDVARK THERAPEUTICS, INC.
18845717 PEST CONTROLLING AGENT Non-Final OA Nippon Kayaku Kabushiki Kaisha

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Svetlana M Ivanova's allowance rate?

50.9% of resolved applications examined by Svetlana M Ivanova were allowed (851 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.

Does an interview help with examiner Svetlana M Ivanova?

This examiner's interview lift is +51.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Svetlana M Ivanova take to allow a patent?

Applications allowed by Svetlana M Ivanova took 978 days on average from filing to allowance.

Which art unit does examiner Svetlana M Ivanova work in?

Svetlana M Ivanova examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month